Skip to main content


Our Technology

Systemic Janus Particles

Systemic Delivery Solution With Janus Particles

Psycheceutical's breakthrough systemic delivery system is designed to use extremely small multi-layered compounds, called Janus particles, to deliver targeted doses of any psychedelic compound directly through the blood-brain barrier, thereby bypassing the liver and reducing toxicity and side effects.

Systemic Delivery - Janus Particles

Key Features:

  • Extremely small size (less than 100nm diameter)
  • Combination of multiple actives delivered in one particle
  • Designed to be easily metabolized and utilized by the body’s cells after delivery of actives
  • Compounds are designed to be delivered intact to target cells for highest efficacy, reducing toxicity or side effects
  • Multi-layered particles designed to enable immediate and sustained relief
  • Working towards overcoming limitations often faced in psychedelic drug development

Patented Janus Particles Manufacturing

We believe that our patented manufacturing process will be able to deliver psychedelics and other complementary compounds at scale, in nearly any required size or shape, in a cost-effective and consistent process. The vision is that our Janus particles will be able to target specific cells and accurately deliver multiple medicines at the same time, or in a time-released manner.

Unlimited Sizes

Particles can be made in virtually any size required and will be uniform across an unlimited number of samples.

Targeted Shapes

Psycheceutical will research the optimal shape and size for each use case. For example, triangular-shaped particles have shown higher absorption by ovarian cancer cells.

Layered Particles

Particles can be layered with multiple actives that can be released at specific intervals. This innovation could make microdosing of psychedelics both reliable and safe.

Janus Particle Patented Manufacturing Technology Goals

  • Issued and pending patents provide worldwide exclusivity for manufacturing and sale of products.
  • Uniform ultra-small nanoparticle structure designed to avoid the body’s immune system.
  • High loading of active compounds to provide low loss of non-sequestered actives and improved manufacturing efficiencies.
  • Process to allow for the efficient production of a high variety of particles with the easy ability to tune for size, shape, and composition.
  • Excellent product stability to provide long shelf life in a wide range of temperature storage conditions.
  • Multi-layered particles to enable delivery of multiple actives from a single dose, at the same time or in time-release.
  • Ability to deliver compounds across the blood-brain barrier, providing a new method for direct delivery of actives directly into the brain.
  • Ability to adapt to oral, mucosal, topical, and parenteral administration provides flexibility in choice of finished dosage formulations.

Discover Our Other Drug

Delivery Technologies


Fill out the form below to get updates delivered directly to your inbox.